[Expression and function of ECRG4 in hepatocellular carcinoma]

Area of Science:

• Oncology
• Molecular Biology
• Hepatology

Background:

• Hepatocellular carcinoma (HCC) is a major global health concern.
• Understanding the molecular mechanisms underlying HCC development is crucial for effective treatment.
• Esophageal cancer related gene 4 (ECRG4) role in HCC is not well-defined.

Purpose of the Study:

• To investigate ECRG4 expression in HCC.
• To determine the functional role of ECRG4 in hepatoma cell proliferation, apoptosis, and migration.

Main Methods:

• ECRG4 expression analyzed in HCC cell lines (QSG7701, HepG2) and 24 primary HCC samples using qPCR and Western blot.
• HepG2 cells were transfected with ECRG4-pcDNA3.1 plasmid to study overexpression effects.
• Cellular proliferation, apoptosis, and migration assays were performed.

Main Results:

• ECRG4 mRNA was significantly reduced or absent in 95.8% of HCC samples compared to normal liver.
• HepG2 cells exhibited lower ECRG4 mRNA and protein levels than QSG7701 cells.
• ECRG4 overexpression in HepG2 cells led to decreased proliferation, increased apoptosis, and reduced migration.

Conclusions:

• ECRG4 is frequently downregulated in HCC, indicating its potential tumor suppressor role.
• ECRG4 overexpression inhibits proliferation and migration while promoting apoptosis in hepatoma cells.
• ECRG4 represents a potential novel therapeutic target for HCC precision therapy.